CRNX · Crinetics Pharmaceuticals, Inc. · Exempt Offerings
Market Cap
$9.01B
Shares
106.07M
Private capital raises reported to the SEC on Form D under Regulation D, showing the offering size, amount sold, minimum investment and number of investors. Public operating companies rarely raise capital this way, so this page is often empty.
Key facts
CIK
1658247
CUSIP
22663K107
13F (30d)
161 filings
161 filers
Visit website
Investor relations